Archives
Adjuvant Nivolumab + Ipilimumab Lacks Efficacy for Localized RCC
Trial did not meet primary efficacy end point of disease-free survival in patients with localized RCC at high risk for postnephrectomy relapse
Multicancer Early Detection Feasible for Outpatients
Specificity for MCED blood test using circulating tumor DNA is 99.1 percent, and positive predictive value is about 40 percent
Model Shows Behavior Changes Could Cut CV Risk in Stage 1 HTN
Adoption of the Dietary Approaches to Stop Hypertension diet may yield largest benefit in reducing cardiovascular events
Some Ultraprocessed Foods May Lead to Broader Consumption for Teens
Study looks at adolescent eating behavior and its implications for modifiable hypertension risk factors
Medical Cannabis Tied to Higher Risk for New Heart Rhythm Disorders
Findings seen for people with chronic pain; no association seen for acute coronary syndrome or heart failure
Cemiplimab Studied as Neoadjuvant Therapy for Cutaneous SCC
In phase 2 study, about half of patients with resectable stage II to IV cutaneous squamous cell carcinoma had pathological complete response
AI Model May Detect COVID-19 Cases Using Voice Changes
Deep learning model based on voice data from crowd-sourced audio samples uses subtle voice changes to detect COVID-19 cases
Air Pollution Increases Heart Attacks in Nonsmokers
Findings for same-day nitric oxide levels and average levels for particulate matter in the preceding three days
Bronchodilator Does Not Improve Respiratory Symptoms for Tobacco-Exposed
No reduction seen in respiratory symptoms for symptomatic, tobacco-exposed persons without formal diagnosis of COPD
SGLT2 Inhibitors Benefit Broad Range of Heart Failure Patients
Risk for cardiovascular death, hospitalization for heart failure reduced regardless of left ventricular ejection fraction